008 | A 3D bioprinted microfluidic Breast Cancer-on-Chip model for studying drug transport and resistance
Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · 31.03.2026 · 99 (s1)
DOI: 10.4081/jbr.2026.15260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, online erschienen am 31.03.2026. Verfasst von Società Italiana di Biologia Sperimentale. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Understanding the complex interactions among tumor cells, stromal components, and vascular networks is essential for the development of effective therapeutic strategies in breast cancer. However, conventional experimental models often fail to reproduce the physiological complexity required to reliably predict drug responses. To address these limitations, a 3D bioprinted microfluidic Breast Cancer-on-Chip platform was developed, incorporating a perfusable, endothelialized microfluidic channel that enables controlled delivery of culture medium and chemotherapeutic agents, thereby mimicking systemic drug administration [1]. The platform integrates patient-derived tumoral constructs generated through 3D bioprinting of self-assembling organoids composed of primary breast cancer epithelial cells, fibroblasts, and endothelial cells. Within this system, cells autonomously organize into structured tumoral assembloids and establish a functional microvascular network capable of invading the surrounding extracellular matrix, recapitulating key features of the tumor microenvironment. Notably, the formation of a dense, collagen-rich capsule surrounding the tumoral assembloids was observed, which appears to hinder the penetration of circulating therapeutics and may contribute to drug resistance. Targeting this endogenous collagen barrier emerges as a promising strategy to enhance intratumoral drug delivery, particularly for nanoparticle-based therapeutic systems. Disruption or modulation of collagen deposition was found to improve therapeutic penetration, potentially increasing the efficacy of both conventional chemotherapeutics and nanomedicine-based formulations. Overall, this Breast Cancer-on-Chip platform represents a versatile and physiologically relevant model for investigating tumor–stroma–vasculature interactions, elucidating mechanisms of drug resistance, and evaluating novel therapeutic approaches within a controlled microfluidic environment.
Zitieren
APA
Sperimentale, S. I. D. B. (2026). 008 | A 3D bioprinted microfluidic Breast Cancer-on-Chip model for studying drug transport and resistance. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, 99(s1). https://doi.org/10.4081/jbr.2026.15260
Vancouver
Sperimentale SIDB. 008 | A 3D bioprinted microfluidic Breast Cancer-on-Chip model for studying drug transport and resistance. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale. 2026;99(s1). doi:10.4081/jbr.2026.15260
BibTeX
@article{Sperimentale2026,
author = {Sperimentale, Società Italiana di Biologia},
title = {008 | A 3D bioprinted microfluidic Breast Cancer-on-Chip model for studying drug transport and resistance},
journal = {Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale},
year = {2026},
volume = {99},
number = {s1},
doi = {10.4081/jbr.2026.15260}
}
EUVIMED